Opposing synaptic regulation of amyloid-ß metabolism by NMDA receptors in vivo.
J Neurosci
; 31(31): 11328-37, 2011 Aug 03.
Article
en En
| MEDLINE
| ID: mdl-21813692
ABSTRACT
The concentration of amyloid-ß (Aß) within the brain extracellular space is one determinant of whether the peptide will aggregate into toxic species that are important in Alzheimer's disease (AD) pathogenesis. Some types of synaptic activity can regulate Aß levels. Here we demonstrate two distinct mechanisms that are simultaneously activated by NMDA receptors and regulate brain interstitial fluid (ISF) Aß levels in opposite directions in the living mouse. Depending on the dose of NMDA administered locally to the brain, ISF Aß levels either increase or decrease. Low doses of NMDA increase action potentials and synaptic transmission which leads to an elevation in synaptic Aß generation. In contrast, high doses of NMDA activate signaling pathways that lead to ERK (extracellular-regulated kinase) activation, which reduces processing of APP into Aß. This depression in Aß via APP processing occurs despite dramatically elevated synaptic activity. Both of these synaptic mechanisms are simultaneously active, with the balance between them determining whether ISF Aß levels will increase or decrease. NMDA receptor antagonists increase ISF Aß levels, suggesting that basal activity at these receptors normally suppresses Aß levels in vivo. This has implications for understanding normal Aß metabolism as well as AD pathogenesis.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Sinapsis
/
Péptidos beta-Amiloides
/
Receptores de N-Metil-D-Aspartato
/
Espacio Extracelular
Idioma:
En
Revista:
J Neurosci
Año:
2011
Tipo del documento:
Article
País de afiliación:
Estados Unidos